News

Prevacus Announces Use of blinktbi’s EyeStat in Upcoming Phase 1 Clinical Study

Prevacus Announces Use of blinktbi’s EyeStat in Upcoming Phase 1 Clinical Study NEWS PROVIDED BY Prevacus, Inc. Jul 13, 2018, 07:30 ET TALLAHASSEE, Fla., July 13, 2018 /PRNewswire/ — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI) and other neurological disorders today announced a partnership with blinktbi, Inc for […]

Read More »

EXCLUSIVE: NFL legend Brett Favre would rather be remembered for ENDING youth tackle football than his Hall of Fame career if it means saving kids from the head traumas he endured for decades

EXCLUSIVE: NFL legend Brett Favre would rather be remembered for ENDING youth tackle football than his Hall of Fame career if it means saving kids from the head traumas he endured for decades After suffering what he estimates to be thousands of concussions during his 20 NFL seasons, Favre is now an outspoken critic of […]

Read More »

Brett Favre, Concussion Victim, Is Backing Research into a Concussion Drug

By JENNY VRENTAS November 07, 2017 On the last play of Brett Favre’s football career, he suffered a concussion. In the seven years since his retirement, the Hall of Fame quarterback has become increasingly honest regarding his concerns about the long-term consequences of the sport through which he made his name. There are times Favre will run into […]

Read More »

A Local Solution for Concussion ‘Epidemic’: Prevacus Could be a Football Sideline Staple

The Prevacus story starts in Tallahassee, specifically at Florida High and Florida State University. Where the story ends is uncertain because nobody has all the answers concerning the long-term effects of concussions. However, the potentially groundbreaking drug could help change that. Prevacus is being developed by Jake VanLandingham, a neuroscientist and a former member of […]

Read More »

Prevacus Announces Appearance on Fox Business

TALLAHASSEE, Fla., Feb. 15, 2017 (GLOBE NEWSWIRE) — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced that Dr. Jake VanLandingham and investor Brett Favre appeared on Fox Business’ “Mornings with Maria” on Friday, February 10, 2017 to discuss the Company’s […]

Read More »

The article featured in The Tallahassee Democrat (seen below) is a perfect example of the many ways Prevacus & it’s team want to help people and the community! Go Noles!

The infusion of new faculty at Florida State University — approximately 200 total professors over the past two years — is already paying off in terms of sponsored research. For the 2014 fiscal year that ended June 30, FSU faculty accumulated slightly more than $230 million in grants and contracts, the bulk of it from federal […]

Read More »